Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
The Pharma Data
SEPTEMBER 20, 2020
executive vice president of Research and Development at Amgen. executive vice president of Research and Development at?Amgen, Amgen’s clinical development team and clinical investigators, will discuss Phase 1 data being presented on the Company’s investigational KRAS G12C ?inhibitor Reese , M.D., Sunday, Sept.
52 
Let's personalize your content